Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).

Name: Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).
Published: 2023
License: Public Domain

Hospital General Universitario de Alicante · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

aorticstenosis glucocorticoids inflammation

heart block, aortic stenosis, bundle-branch block, transcatheter aortic valve replacement, glucocorticoids, inflammation, conduction disturbances, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).

Related documents